Literature DB >> 30422887

Cannabidiol-Induced Acute Generalized Exanthematous Pustulosis.

Cory Pettit, Susan Massick1, Mark Bechtel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30422887     DOI： 10.1097/DER.0000000000000422

Source DB:  PubMed          Journal:  Dermatitis        ISSN： 1710-3568            Impact factor:   4.845


× No keyword cloud information.
  6 in total

1.  Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology.

Authors:  Jennifer Laborada; Philip R Cohen
Journal:  Cureus       Date:  2022-04-05

2.  Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations.

Authors:  José Diogo S Souza; Maíra Fassoni-Ribeiro; Rayssa Miranda Batista; Juliana Mayumi Ushirohira; Antonio W Zuardi; Francisco S Guimarães; Alline C Campos; Flávia de Lima Osório; Daniel Elias; Cacilda S Souza; AndRea A Fassoni; Jaime E C Hallak; José Alexandre S Crippa
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 3.  Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.

Authors:  Paul C Macklis; Brittany Dulmage; Brady Evans; Misha Rosenbach; Johann E Gudjonsson; Benjamin H Kaffenberger
Journal:  Drugs R D       Date:  2020-09

4.  Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome.

Authors:  Han Y Yin; Nicholas Hadjokas; Kanish Mirchia; Robert Swan; Samuel Alpert
Journal:  Case Rep Ophthalmol Med       Date:  2020-02-19

Review 5.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

Review 6.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.